Tradestie Institutional Equity Comparison Engine

EW vs PHG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EW Overall Edge

EW Captures Institutional Edge (2โ€“2 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical while PHG counters with relative strength in Valuation, Options & Structure. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus PHG at 14.9x Forward P/E and 8.8% operating margin (+2.1% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against PHG sits in SURGE (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PHG
EW 31.6x vs PHG 14.9x Fwd P/E
Growth & Margin Winner EW
Op Margin 28.8% vs 8.8% ยท YoY +10.5% vs +2.1%
Momentum & Technical Winner EW
1Y +23.9% vs +4.5% ยท 52W Pos 96% vs 67%
Options & Structure Winner PHG
UNCLASSIFIED (34th %ile IV) vs SURGE (2nd %ile IV)
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap $60.8B
1M Return +23.16%
1Y Return +23.86%
Forward P/E 31.6x
Unified AI Score
31.5 / 100 SELL
Tech 50.0 Fund 29.0 Flow 51.0 Mom 44.0
PHG NYSE
Koninklijke Philips N.V.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$30.21
-0.43% 1D
Market Cap $29.6B
1M Return +17.37%
1Y Return +4.46%
Forward P/E 14.9x
Unified AI Score
28.4 / 100 SELL
Tech 50.0 Fund 23.0 Flow 54.0 Mom 11.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EW +23.86% PHG +4.46% Spread: +19.4 pp (EW Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EW Revenue PHG Revenue EW Op. Margin PHG Op. Margin Margin Edge
Q3 '25 $6.21B $8.44B 27.4% 7.7% EW
Q4 '25 $6.28B $10.0B 23.6% 11.1% EW
Q1 '26 $6.59B $7.66B 31.2% 6.2% EW
Q2 '26 $6.96B $8.55B 29.8% 14.0% EW
Q3 '26 $6.86B $8.62B 30.2% 3.8% EW

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EW (9) vs PHG (1)
Institutional Metric EW PHG Criterion Row Winner
Market Capitalization Scale $60.8B $29.6B Larger Scale EW
Trailing P/E Ratio Valuation 61.5x 63.2x Lower Multiple EW
Forward P/E Ratio Valuation 31.6x 14.9x Lower Multiple PHG
Revenue Growth (YoY) Growth +10.5% +2.1% Higher Growth EW
Operating Margin (TTM) Profitability 28.8% 8.8% Higher Margin EW
Net Profit Margin Profitability 15.3% 5.4% Higher Margin EW
Return on Equity (ROE) Capital Efficiency 9.3% 8.6% Higher ROE EW
52-Week Range Position Momentum 96% ($75โ€“$108) 67% ($24โ€“$33) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 24% Vol 0.73ฮฒ ยท 38% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 28.4 / 100 (SELL) Higher Composite EW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EW vs PHG Buy Guide
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PHG SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PHG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EW nor PHG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.